References

10.1056/nejmra1405427

10.1056/nejmra1405427 · External reference

Tuberculosis Infection in Children and Adolescents

10.3390/pathogens11121512 · 2022 · External reference

Unresolved reference

External reference

10.1016/s1473-3099(08)70182-8

10.1016/s1473-3099(08)70182-8 · External reference

Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB

2013 · External reference

Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis

10.1186/1471-2334-14-91 · 2014 · External reference

Adherence to isoniazid preventive therapy in children exposed to tuberculosis: a prospective study from Guinea-Bissau

10.5588/ijtld.10.0558 · 2011 · External reference

10.7326/m17-0609

10.7326/m17-0609 · External reference

10.1136/archdischild-2013-303876

10.1136/archdischild-2013-303876 · External reference

Isoniazid for preventing tuberculosis in HIV-infected children

2017 · External reference

Effectiveness and safety of available preventive tuberculosis treatment regimens for children and adolescents: protocol for a systematic review and network meta-analysis

10.1136/bmjpo-2022-001551 · 2022 · External reference

Unresolved reference

External reference

10.7326/m14-2385

10.7326/m14-2385 · External reference

Unresolved reference

External reference

10.1093/cid/ciw778

10.1093/cid/ciw778 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

10.1016/j.jclinepi.2024.111537

10.1016/j.jclinepi.2024.111537 · External reference

Network meta-analysis: application and practice using Stata

10.4178/epih.e2017047 · 2017 · External reference

A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis

10.1136/bmj.g5630 · 2014 · External reference

10.1016/j.jclinepi.2023.06.010

10.1016/j.jclinepi.2023.06.010 · External reference

10.1016/j.jclinepi.2018.11.025

10.1016/j.jclinepi.2018.11.025 · External reference

A controlled pilot study among household contacts of tuberculosis cases

1965 · External reference

10.1086/520983

10.1086/520983 · External reference

Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid

10.1001/jamapediatrics.2014.3158 · 2015 · External reference

Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood--a pilot project

1994 · External reference

The use of isoniazid among household contacts of open cases of pulmonary tuberculosis

1965 · External reference

10.1056/nejmoa1714284

10.1056/nejmoa1714284 · External reference

A controlled trial of community-wide isoniazid prophylaxis in Alaska

1967 · External reference

Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study

10.1186/s12879-015-1201-8 · 2015 · External reference

Isoniazid prophylaxis in contacts of persons with known tuberculosis. Second report

1965 · External reference

Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts

1962 · External reference

Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis

1998 · External reference

Risk of infection and disease progression in children exposed to tuberculosis at home, Colombia

10.25100/cm.v50i4.4185 · 2019 · External reference

Improving Tuberculosis Medication Adherence: The Potential of Integrating Digital Technology and Health Belief Model

10.4046/trd.2022.0148 · 2023 · External reference

Clinical practice guideline for the evaluation, treatment, and follow-up of children in contact with patients with pulmonary tuberculosis in Colombia

10.25100/cm.v56i1.5918 · 2025 · External reference

Current management options for latent tuberculosis: a review

2012 · External reference

Anti-Tuberculosis Drug Induced Hepatotoxicity and Associated Factors among Tuberculosis Patients at Selected Hospitals, Ethiopia

2021 · External reference

Antituberculosis drug-induced hepatotoxicity in children

10.4081/pr.2011.e16 · 2011 · External reference

The effectiveness of preventive tuberculosis treatment in children

10.1186/s12879-026-12726-8 · 2026 · External reference

Adherence to treatment for tuberculosis infection in children using a comprehensive care strategy: a prospective cohort study with a historical control group

2025 · External reference

Use of Isoniazid Monotherapy in Comparison to Rifamycin-Based Regimen for the Treatment of Patients With Latent Tuberculosis: A Systematic Review

2022 · External reference

10.3201/eid1209.051606

10.3201/eid1209.051606 · External reference

Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies

10.1016/s2213-2600(24)00083-3 · 2024 · External reference

Efficacy and safety of different regimens in the treatment of patients with latent tuberculosis infection: a systematic review and network meta-analysis of randomized controlled trials

10.1186/s13690-023-01098-z · 2023 · External reference

10.1093/cid/ciad246

10.1093/cid/ciad246 · External reference

Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003

2003 · External reference

Patient and provider preferences for long-acting TB preventive therapy

10.5588/ijtldopen.24.0670 · 2025 · External reference

A Novel Therapy With a One-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB‑YOUTH Study): Protocol for a Cluster Randomized Controlled Trial

10.2196/89584 · 2026 · External reference